Tim Shannon Email & Phone Number

Southampton, Pennsylvania, Us

NewAge Industries is a market leading manufacturer of high-quality fluid transfer products to the medical, industrial, and food and beverage industries. From PVC, polyurethane, and silicone to specialty and custom materials, our products add value to endless standard and clean applications. With extensive testing and rigorous quality control procedures, our products meet high regulatory compliance requirements. We maintain a large on-hand inventory of finished products, materials, and components and are proud to be a trusted source for multiple product solutions and creative project engineering insights. In 2019, NewAge became 100% employee owned. The ESOP highlights the company’s complete commitment from all employees to the success of its partners and to the overall health of the organization.

I drive business consulting, foster commercial growth, and establish a resilient global supply chain through strategic leadership and innovation. My efforts have significantly contributed to the success and growth of the organization, particularly in pioneering the development of an extensive global supply chain, ensuring secure and efficient sourcing of vital medical products. My role enables me to excel in implementing market expansion initiatives, successfully entering new geographical regions, and capturing market share, while consistently identifying and integrating cutting-edge technologies to enhance business processes and maintain competitiveness in the market. Furthermore, my commitment to driving operational efficiency, reducing costs, and optimizing business processes has resulted in measurable achievements, reflecting the organization's dedication to excellence and innovation.

Heerlen, Limburg, Nl

As the Business Unit Director/VP & General Manager, I successfully integrating three distinct selling organizations into a unified global structure. Through meticulous planning and execution, I played a pivotal role in achieving a remarkable 10% growth in both revenue and EBITDA in 2019, setting the stage for the company's continued success in the regenerative materials sector.In my capacity, I held responsibility for implementing cost-effective measures to optimize operational efficiency and ensure the company met its financial targets. My leadership not only controlled the financial aspects but also ensured the successful delivery of results, further solidifying the company's position as a key player in the industry. Through a combination of strategic foresight, negotiation prowess, and effective financial management, I contributed to the growth and profitability of the $75M Regenerative Materials Business unit.

Heerlen, Limburg, Nl

In my key performance as the President-Ad Interim for DSM Biomedical, I provided visionary leadership to the entire Biomedical CDMO, overseeing all functional heads, delivering on a $200M P&L, while directing a diverse team of 445 employees across four manufacturing sites. Subsequently, I strategically navigated complex operational landscapes, ensuring optimal performance and cross-functional collaboration. Instrumental in driving innovation, I managed a portfolio of 9 biologic technologies integral to the development of cutting-edge noninvasive and implantable medical devices, positioning DSM Biomedical as a leader in the industry. Additionally, I excelled in customer relationship management, implementing sales and marketing strategies that contributed to revenue growth and market expansion.

Vancouver, British Columbia, Ca

I played a pivotal role in driving the company's global expansion and market dominance. By establishing a Wholly Owned Foreign Enterprise (WOFE) in Shanghai, China, I successfully expanded the Asian market footprint, strategically positioning the company for exponential growth. Through the execution of a robust global distribution matrix spanning BRICs, Europe, and the US, I led initiatives that fostered international growth and market penetration, establishing Response Biomedical as a key player on the global stage.In addition, I orchestrated a significant restructuring of the distribution model within China, not only increasing profitability but also ensuring a more efficient and strategic approach to capturing market share. Furthermore, within the first 90 days of my tenure, I spearheaded a comprehensive rebranding initiative, overseeing a website overhaul, implementing peripheral marketing strategies, and redesigning corporate materials.

Wayne, Pa, Us

As the Vice President of Vascular/RTP, I successfully managed a $200M-dollar portfolio overseeing the entire Teleflex Vascular product line, which included a comprehensive range of Central Venous Catheters (CVC) and Peripherally Inserted Central Catheters (PICC). My responsibilities centered around developing and executing effective sales and downstream marketing strategies. Additionally, I was honored to be recognized as an "officer" on the new Executive Board of the Vascular Division, where I led a high-performance team of 135 professionals, contributing to the division's overall success.During my tenure, I inherited a growth rate of 0.05% in the first half of 2011. Through the implementation of strategic initiatives, I achieved remarkable results, driving growth rates to 6.7% in the second half of 2011, 14.2% in the first quarter of 2012, and 8.0% in the first half of 2012. I have played a pivotal role in transforming the division's performance to drive substantial growth and foster excellence within the organization.

Gothenburg, Se

Chicago, Us

Launched the world's first ever surgical laparoscopic cholecystectomy procedure to the market as well as the world's first ever vascular closure device.